Baxter works to get North Carolina IV plants back online as national shortages loom

Baxter is pouring resources into its North Cove manufacturing site in western North Carolina to get it back online after it was flooded by Hurricane Helene. The plant, which supplies 60% of IV bag in the United States, sits on a river in the mountains, where contaminated waters permeated the facility. 

Two bridges that allow access to the site were also badly damaged. 

Baxter said in an Oct. 7 update that it is working to get its existing stocks in storage at the plant out into the supply chain, in hopes of mitigating a potential national shortage. It is also making steady progress on cleanup and remediation. A big accomplishment in the past few days was the construction of a temporary rock bridge built over the river, which is now supporting transport in and out of the site.

"We expect a second bridge will be installed by the North Carolina Department of Transportation soon. We have not identified any structural damage to the facility to date, and we anticipate engineering certification within the next two weeks," Baxter said in a statement.

Electrical power to the site is now available. The local aquifer, which is the main source of water used in the manufacturing process, is intact and usable, the company said.

"Remediation is progressing, and we expect to begin communicating anticipated production plans within the next two weeks," Baxter added. 

More than 500 workers from best-in-class remediation firms are now working onsite. That number could reach 1,0000 next week.

Recovery of existing IV stock underway

This past weekend, using the newly built rock bridge, Baxter moved finished products that were stored in semitrailers and not implanted by the flooding out of the North Cove plant site to another location outside of the disaster area.

"We have resumed shipments to hospitals and dialysis patients at previously communicated allocation levels after the temporary hold last week and are ramping up production in several global plants to help meet U.S. needs," Baxter said.

Baxter started calling back some of the plant employees late last week to help with cleanup efforts. Some workers on social media commented that the production lines they work on are intact, but in need of serious cleaning before they're operational. One worker predicted they might have cleanup completed by next week.

Baxter is also calling some employees back to work who are involved in sterilization to help to help rework additional product that is already onsite.

The flooded Baxter North Cove IV bag plant in North Carolina with its flags at half mast for the more than 250 people killed by Hurricane Helene, including at least one Baxter employee. Baxter photo

Flags at half mast at the North Cove, North Carolina, IV plant for the more than 250 people killed by Hurricane Helene, including at least one Baxter employee. Photo from Baxter. 

Rationing implemented on Baxter IV orders

To manage its dwindling supply of IV bags and ensure equitable access to the available products, Baxter implemented rating of its supplies with limits on orders. Additional information on product availability is being communicated directly to its customers, distributors and the group purchasing organizations (GPOs).

Read Baxter's Oct. 1 letter for home dialysis customers

Read Baxter's Sept. 30 letter for healthcare facilities

Federal agencies are working with Baxter

Dawn O'Connell, assistant secretary for preparedness and response for the U.S. Department of Health and Human Services (HHS) discussed the Baxter plant shutdown at a press conference at Mission Hospital in Asheville on Oct. 5. She said maintaining the medical health supply chain is a priority for HHS and they have spoken with Baxter's CEO immediately after the storm  passed and the damaged was being assessed. She said HHS has been daily contact with Baxter officials since.

"Baxter fortunately have plants across the world that they are looking to access supply from and bring in. The difficulty right now for them of being able to access their plant. There is a bridge that went out that would bring things back and forth," O'Connell explained. "They invested in this on their own and put in a rock bridge to get some of the machines in to help augment and begin cleanup to get the plant back online."

Baxter said in a statement it has received tremendous support from state and local officials, including from the HHS's Administration for Strategic Preparedness and Response (ASPR) and the Federal Emergency Management Agency (FEMA). This includes expediting immediate replacement of the country bridge that was badly damage. Baxter said it expects a permanent bridge will be installed by the Army Corps of Engineers and North Carolina Department of Transportation in the coming weeks.

Andrea Palmer, deputy secretary of the U.S. Department of Health and Human Services, also spoke at the press conference and said the FDA is also in contact with other vendors that make IV supplies to try and get them to ramp up production, at least temporarily, to help overcome shortages while Baxter works to recover its stocks and get its plant back up and running.

North Cove employees are also victims of the storm

Baxter has opened a supply depot to help employees six miles south of the North Cove plant get what they need in terms of food and household supplies, including generators. The site is also offering access to showers, bathrooms and a laundromat. 

Many Baxter employees had homes damaged, and in some cases swept away by mudslides and torrential flooding in the mountain valleys of the area. Others live in remote areas and are cut off and isolated because of downed trees and washed-out roads and bridges. At least one Baxter employee was killed in a mudslide that swept her home into a river.

"We continue to support our employees as they begin the recovery process. The vast majority of employees are accounted for, and we are still working to reach a small number of our colleagues. Outreach to those employees in remote locations, where people are having difficulty getting out of their homes due to damaged roads and bridges, continues door-to-door on ATVs. Supplies, electricity, and cell service remain very limited in the area," Baxter said in a statement.

Baxter has continued paying employees since the plant has been closed. The company is also offering onsite counseling and financial assistance options, including Baxter’s Employee Disaster Relief Fund to help with personal property damage and emergency expenses.  

Overall, workers at the North Cove plant say in social media comments they are very happy with the support Baxter has given them and there is a wide sense of family and mission to saving lives with the work they do at the plant.

"The amount of vast supplies Baxter is offering and the amount of support we have received from this company is just unheard of. No other company is doing anywhere near what Baxter is. Very thankful for where we work," one employee wrote.

"Baxter has been amazing. For the year and a half I’ve worked there, both my leadership and coworkers have been like a second family, and the company has 100% done better than I would have imagined through this disaster," another employee wrote.

Baxter volunteers sort relief supplies for employees of its North Cove, North Carolina, IV manufacturing plant. many of the plant's 2,500 employees were impacted, including damaged or destroyed homes, vehicles or being cut off in remote areas due to roads and bridges being washed out. Baxter Photo

Volunteers sort through relief supplies for Baxter employees. Photo from Baxter.

Dave Fornell is a digital editor with Cardiovascular Business and Radiology Business magazines. He has been covering healthcare for more than 16 years.

Dave Fornell has covered healthcare for more than 17 years, with a focus in cardiology and radiology. Fornell is a 5-time winner of a Jesse H. Neal Award, the most prestigious editorial honors in the field of specialized journalism. The wins included best technical content, best use of social media and best COVID-19 coverage. Fornell was also a three-time Neal finalist for best range of work by a single author. He produces more than 100 editorial videos each year, most of them interviews with key opinion leaders in medicine. He also writes technical articles, covers key trends, conducts video hospital site visits, and is very involved with social media. E-mail: dfornell@innovatehealthcare.com

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.